Cancer and neoplasms
Skin
Cutaneous SCC prevention using topical therapy in immunosuppressed patients (SPOT-IT)
Background: Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer with metastatic potential and has an identifiable precancerous stage,actinic keratosis (AK). cSCC incidence exceeds 52,000 in UK and is increasing by 5% per annum with immunosuppression as a key risk factor. Multiple primary cSCC are common,especially in immunosuppressed organ transplant recipients,and incur significant morbidity and cost. Prevention of cSCC in immunosuppressed patients is a major unmet clinical need,yet this population has previously been excluded RCT data confirm that ...
GO TO STUDY